Cargando…

A Comparison of the Blood Glucose, Growth Hormone, and Cortisol Responses to Two Doses of Insulin (0.15 U/kg vs. 0.10 U/kg) in the Insulin Tolerance Test: A Single-Centre Audit of 174 Cases

OBJECTIVE: The insulin tolerance test (ITT) is the gold standard endocrine test used to assess the integrity of the growth hormone (GH) and cortisol axes. The ITT has potential risks, and severe hypoglycaemia may necessitate intravenous glucose rescue. There is no clear consensus as to the optimal i...

Descripción completa

Detalles Bibliográficos
Autores principales: Yeoh, Phillip, Dwyer, Andrew A., Anghel, Ella, Bouloux, Pierre M., Khoo, Bernard, Chew, Shern, Wernig, Florian, Carroll, Paul, Aylwin, Simon J. B., Baldeweg, Stephanie E., Drake, William, Todd, Jeannie, Mangena, Lindiwe, Grossman, Ashley
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9019435/
https://www.ncbi.nlm.nih.gov/pubmed/35465075
http://dx.doi.org/10.1155/2022/7360282
_version_ 1784689276710027264
author Yeoh, Phillip
Dwyer, Andrew A.
Anghel, Ella
Bouloux, Pierre M.
Khoo, Bernard
Chew, Shern
Wernig, Florian
Carroll, Paul
Aylwin, Simon J. B.
Baldeweg, Stephanie E.
Drake, William
Todd, Jeannie
Mangena, Lindiwe
Grossman, Ashley
author_facet Yeoh, Phillip
Dwyer, Andrew A.
Anghel, Ella
Bouloux, Pierre M.
Khoo, Bernard
Chew, Shern
Wernig, Florian
Carroll, Paul
Aylwin, Simon J. B.
Baldeweg, Stephanie E.
Drake, William
Todd, Jeannie
Mangena, Lindiwe
Grossman, Ashley
author_sort Yeoh, Phillip
collection PubMed
description OBJECTIVE: The insulin tolerance test (ITT) is the gold standard endocrine test used to assess the integrity of the growth hormone (GH) and cortisol axes. The ITT has potential risks, and severe hypoglycaemia may necessitate intravenous glucose rescue. There is no clear consensus as to the optimal insulin dose for the ITT. Therefore, we sought to compare the standard dose (0.15 U/kg) and a low-dose ITT (0.1 U/kg). DESIGN: Single-centre audit of ITT data (2012–2021). Patients and Measurements. Patients who underwent an ITT to assess possible GH deficiency/adrenal insufficiency were included. Glucose, GH, and cortisol were measured at baseline and 30, 45, 60, 90, and 120 minutes following I.V. insulin bolus (0.15 U/kg or 0.10 U/kg). RESULTS: Of the ITTs performed, only 3/177 (1.7%) did not achieve adequate hypoglycaemia (≤2.2 mmol/L) with a single insulin dose. In total, 174 patients (43.5 ± 12.1 yrs, mean ± standard deviation) were included for analysis (0.15 U/kg: n = 113, 0.10 U/kg: n = 61). All 174 subjects had adequate hypoglycaemia regardless of baseline fasting blood glucose level or insulin dose. Neither nadir glucose nor glucose delta (i.e., baseline minus nadir) differed between insulin doses. Trends in both cortisol and GH responses over time were similar between groups, and a greater proportion of patients receiving the standard dose had an adequate cortisol response (77/106 (72.6%) vs. 32/60 (53.3%), p=0.01). The rates of glucose rescue did not differ in a subset of 79 patients, with on-demand glucose rescue in 4/35 (11%) for the standard dose and 2/44 (5%) for the low dose (p=0.25). CONCLUSIONS: Our results suggest that the low-dose ITT produces comparable glucose, cortisol, and GH responses to the higher dose. Given the risks associated with hypoglycaemia, the low dose appears to be preferable to the standard dose ITT in most circumstances.
format Online
Article
Text
id pubmed-9019435
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Hindawi
record_format MEDLINE/PubMed
spelling pubmed-90194352022-04-21 A Comparison of the Blood Glucose, Growth Hormone, and Cortisol Responses to Two Doses of Insulin (0.15 U/kg vs. 0.10 U/kg) in the Insulin Tolerance Test: A Single-Centre Audit of 174 Cases Yeoh, Phillip Dwyer, Andrew A. Anghel, Ella Bouloux, Pierre M. Khoo, Bernard Chew, Shern Wernig, Florian Carroll, Paul Aylwin, Simon J. B. Baldeweg, Stephanie E. Drake, William Todd, Jeannie Mangena, Lindiwe Grossman, Ashley Int J Endocrinol Research Article OBJECTIVE: The insulin tolerance test (ITT) is the gold standard endocrine test used to assess the integrity of the growth hormone (GH) and cortisol axes. The ITT has potential risks, and severe hypoglycaemia may necessitate intravenous glucose rescue. There is no clear consensus as to the optimal insulin dose for the ITT. Therefore, we sought to compare the standard dose (0.15 U/kg) and a low-dose ITT (0.1 U/kg). DESIGN: Single-centre audit of ITT data (2012–2021). Patients and Measurements. Patients who underwent an ITT to assess possible GH deficiency/adrenal insufficiency were included. Glucose, GH, and cortisol were measured at baseline and 30, 45, 60, 90, and 120 minutes following I.V. insulin bolus (0.15 U/kg or 0.10 U/kg). RESULTS: Of the ITTs performed, only 3/177 (1.7%) did not achieve adequate hypoglycaemia (≤2.2 mmol/L) with a single insulin dose. In total, 174 patients (43.5 ± 12.1 yrs, mean ± standard deviation) were included for analysis (0.15 U/kg: n = 113, 0.10 U/kg: n = 61). All 174 subjects had adequate hypoglycaemia regardless of baseline fasting blood glucose level or insulin dose. Neither nadir glucose nor glucose delta (i.e., baseline minus nadir) differed between insulin doses. Trends in both cortisol and GH responses over time were similar between groups, and a greater proportion of patients receiving the standard dose had an adequate cortisol response (77/106 (72.6%) vs. 32/60 (53.3%), p=0.01). The rates of glucose rescue did not differ in a subset of 79 patients, with on-demand glucose rescue in 4/35 (11%) for the standard dose and 2/44 (5%) for the low dose (p=0.25). CONCLUSIONS: Our results suggest that the low-dose ITT produces comparable glucose, cortisol, and GH responses to the higher dose. Given the risks associated with hypoglycaemia, the low dose appears to be preferable to the standard dose ITT in most circumstances. Hindawi 2022-02-08 /pmc/articles/PMC9019435/ /pubmed/35465075 http://dx.doi.org/10.1155/2022/7360282 Text en Copyright © 2022 Phillip Yeoh et al. https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
Yeoh, Phillip
Dwyer, Andrew A.
Anghel, Ella
Bouloux, Pierre M.
Khoo, Bernard
Chew, Shern
Wernig, Florian
Carroll, Paul
Aylwin, Simon J. B.
Baldeweg, Stephanie E.
Drake, William
Todd, Jeannie
Mangena, Lindiwe
Grossman, Ashley
A Comparison of the Blood Glucose, Growth Hormone, and Cortisol Responses to Two Doses of Insulin (0.15 U/kg vs. 0.10 U/kg) in the Insulin Tolerance Test: A Single-Centre Audit of 174 Cases
title A Comparison of the Blood Glucose, Growth Hormone, and Cortisol Responses to Two Doses of Insulin (0.15 U/kg vs. 0.10 U/kg) in the Insulin Tolerance Test: A Single-Centre Audit of 174 Cases
title_full A Comparison of the Blood Glucose, Growth Hormone, and Cortisol Responses to Two Doses of Insulin (0.15 U/kg vs. 0.10 U/kg) in the Insulin Tolerance Test: A Single-Centre Audit of 174 Cases
title_fullStr A Comparison of the Blood Glucose, Growth Hormone, and Cortisol Responses to Two Doses of Insulin (0.15 U/kg vs. 0.10 U/kg) in the Insulin Tolerance Test: A Single-Centre Audit of 174 Cases
title_full_unstemmed A Comparison of the Blood Glucose, Growth Hormone, and Cortisol Responses to Two Doses of Insulin (0.15 U/kg vs. 0.10 U/kg) in the Insulin Tolerance Test: A Single-Centre Audit of 174 Cases
title_short A Comparison of the Blood Glucose, Growth Hormone, and Cortisol Responses to Two Doses of Insulin (0.15 U/kg vs. 0.10 U/kg) in the Insulin Tolerance Test: A Single-Centre Audit of 174 Cases
title_sort comparison of the blood glucose, growth hormone, and cortisol responses to two doses of insulin (0.15 u/kg vs. 0.10 u/kg) in the insulin tolerance test: a single-centre audit of 174 cases
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9019435/
https://www.ncbi.nlm.nih.gov/pubmed/35465075
http://dx.doi.org/10.1155/2022/7360282
work_keys_str_mv AT yeohphillip acomparisonofthebloodglucosegrowthhormoneandcortisolresponsestotwodosesofinsulin015ukgvs010ukgintheinsulintolerancetestasinglecentreauditof174cases
AT dwyerandrewa acomparisonofthebloodglucosegrowthhormoneandcortisolresponsestotwodosesofinsulin015ukgvs010ukgintheinsulintolerancetestasinglecentreauditof174cases
AT anghelella acomparisonofthebloodglucosegrowthhormoneandcortisolresponsestotwodosesofinsulin015ukgvs010ukgintheinsulintolerancetestasinglecentreauditof174cases
AT boulouxpierrem acomparisonofthebloodglucosegrowthhormoneandcortisolresponsestotwodosesofinsulin015ukgvs010ukgintheinsulintolerancetestasinglecentreauditof174cases
AT khoobernard acomparisonofthebloodglucosegrowthhormoneandcortisolresponsestotwodosesofinsulin015ukgvs010ukgintheinsulintolerancetestasinglecentreauditof174cases
AT chewshern acomparisonofthebloodglucosegrowthhormoneandcortisolresponsestotwodosesofinsulin015ukgvs010ukgintheinsulintolerancetestasinglecentreauditof174cases
AT wernigflorian acomparisonofthebloodglucosegrowthhormoneandcortisolresponsestotwodosesofinsulin015ukgvs010ukgintheinsulintolerancetestasinglecentreauditof174cases
AT carrollpaul acomparisonofthebloodglucosegrowthhormoneandcortisolresponsestotwodosesofinsulin015ukgvs010ukgintheinsulintolerancetestasinglecentreauditof174cases
AT aylwinsimonjb acomparisonofthebloodglucosegrowthhormoneandcortisolresponsestotwodosesofinsulin015ukgvs010ukgintheinsulintolerancetestasinglecentreauditof174cases
AT baldewegstephaniee acomparisonofthebloodglucosegrowthhormoneandcortisolresponsestotwodosesofinsulin015ukgvs010ukgintheinsulintolerancetestasinglecentreauditof174cases
AT drakewilliam acomparisonofthebloodglucosegrowthhormoneandcortisolresponsestotwodosesofinsulin015ukgvs010ukgintheinsulintolerancetestasinglecentreauditof174cases
AT toddjeannie acomparisonofthebloodglucosegrowthhormoneandcortisolresponsestotwodosesofinsulin015ukgvs010ukgintheinsulintolerancetestasinglecentreauditof174cases
AT mangenalindiwe acomparisonofthebloodglucosegrowthhormoneandcortisolresponsestotwodosesofinsulin015ukgvs010ukgintheinsulintolerancetestasinglecentreauditof174cases
AT grossmanashley acomparisonofthebloodglucosegrowthhormoneandcortisolresponsestotwodosesofinsulin015ukgvs010ukgintheinsulintolerancetestasinglecentreauditof174cases
AT yeohphillip comparisonofthebloodglucosegrowthhormoneandcortisolresponsestotwodosesofinsulin015ukgvs010ukgintheinsulintolerancetestasinglecentreauditof174cases
AT dwyerandrewa comparisonofthebloodglucosegrowthhormoneandcortisolresponsestotwodosesofinsulin015ukgvs010ukgintheinsulintolerancetestasinglecentreauditof174cases
AT anghelella comparisonofthebloodglucosegrowthhormoneandcortisolresponsestotwodosesofinsulin015ukgvs010ukgintheinsulintolerancetestasinglecentreauditof174cases
AT boulouxpierrem comparisonofthebloodglucosegrowthhormoneandcortisolresponsestotwodosesofinsulin015ukgvs010ukgintheinsulintolerancetestasinglecentreauditof174cases
AT khoobernard comparisonofthebloodglucosegrowthhormoneandcortisolresponsestotwodosesofinsulin015ukgvs010ukgintheinsulintolerancetestasinglecentreauditof174cases
AT chewshern comparisonofthebloodglucosegrowthhormoneandcortisolresponsestotwodosesofinsulin015ukgvs010ukgintheinsulintolerancetestasinglecentreauditof174cases
AT wernigflorian comparisonofthebloodglucosegrowthhormoneandcortisolresponsestotwodosesofinsulin015ukgvs010ukgintheinsulintolerancetestasinglecentreauditof174cases
AT carrollpaul comparisonofthebloodglucosegrowthhormoneandcortisolresponsestotwodosesofinsulin015ukgvs010ukgintheinsulintolerancetestasinglecentreauditof174cases
AT aylwinsimonjb comparisonofthebloodglucosegrowthhormoneandcortisolresponsestotwodosesofinsulin015ukgvs010ukgintheinsulintolerancetestasinglecentreauditof174cases
AT baldewegstephaniee comparisonofthebloodglucosegrowthhormoneandcortisolresponsestotwodosesofinsulin015ukgvs010ukgintheinsulintolerancetestasinglecentreauditof174cases
AT drakewilliam comparisonofthebloodglucosegrowthhormoneandcortisolresponsestotwodosesofinsulin015ukgvs010ukgintheinsulintolerancetestasinglecentreauditof174cases
AT toddjeannie comparisonofthebloodglucosegrowthhormoneandcortisolresponsestotwodosesofinsulin015ukgvs010ukgintheinsulintolerancetestasinglecentreauditof174cases
AT mangenalindiwe comparisonofthebloodglucosegrowthhormoneandcortisolresponsestotwodosesofinsulin015ukgvs010ukgintheinsulintolerancetestasinglecentreauditof174cases
AT grossmanashley comparisonofthebloodglucosegrowthhormoneandcortisolresponsestotwodosesofinsulin015ukgvs010ukgintheinsulintolerancetestasinglecentreauditof174cases